Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to…
Artmarket.com publishes its 32nd Artprice Annual Report – The Art Market in 2025 – showing 12% growth, with the USA strengthening its dominant position. Plus Gemini Deep Think’s AI audit of Artprice’s strategy for 2026/2030
PARIS, March 10, 2026 /PRNewswire/ -- The 32nd Artprice Annual Report –…
India Deep Tech Alliance Issues Inaugural Report Showing AI Funding Jumps 58% in 2025, Fast-Tracks $1B USD Investment to AI Startup Funding
Report maps India AI and deep tech investment surge and next wave…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at ObesityWeek
CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE)…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
New REDUCE-IT Analyses Presented at ESC 2025 Include Data Showing VASCEPA/VAZKEPA (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl…
Spectacle in South Africa: Two Chery TIGGO9 Models Collide Head-On, Showing Flawless Safety Performance
JOHANNESBURG, Aug. 21, 2025 /PRNewswire/ -- On August 20, two Chery TIGGO9 flagship…
adidas and AllStar Line Up Celebrate the UEFA Womens EUROS by Showing the Power of Competition in Helping to Make Athletes Believe You Got This
adidas unveils a film that positions competition as a positive aspect of…
